“Assessment of Serum Levels of CA19-9 and Amylin in Relation to Glycemic Control in Type-2 Diabetic Patients”, AIMCJ, vol. 3, no. 2, pp. 142–156, Aug. 2026, doi: 10.58564/AIMCJ3.2.2026.322.